Clinical Trial Update: A Comparison Study of Prototype Continuous Glucose Sensors in the Intradermal and Subcutaneous Spaces [Phase 1]

View source ↗

Summary

A Phase 1 trial comparing prototype continuous glucose sensors placed intradermally versus in subcutaneous tissue has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Snippet

Sponsor: Becton, Dickinson and Company | Conditions: Diabetes | Phase 1 | Status: COMPLETED